Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05847738
Other study ID # FD-BUE-REC 23-002
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 15, 2023
Est. completion date April 15, 2023

Study information

Verified date May 2023
Source British University In Egypt
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a randomized controlled parallel clinical, prospective split mouth, triple blinded study. Sample size calculation was conducted and it was 25 subjects per group for a total of 50 sides to compensate for drop-outs. Patient selection and preparation: All root canal treatments were performed by a single endodontic consultant. All subjects were selected from walk in patients presented to the endodontic clinic of the British university in Egypt. Cases that met the inclusion criteria where selected for this study. All patients were verbally informed about the procedure's benefits and that the results of the treatment will be used to this study and the risks of the procedure was explicitly explained to them. After the verbal consent patients were handed a written form consent to sign upon. All data of post-operative pain were recorded by a second blinded clinician through a visual analog scale (VAS). Post-operative monitoring periods will be recorded in 12 hours, 24 hours, 3 days and one week Data was sent to the statistician with group names only to fulfill the triple blinding criteria and results will be interpreted


Description:

This is a randomized controlled parallel clinical, prospective split mouth, triple blinded study. Sample size calculation was conducted using G*Power 3.1.9.4 software based on data obtained from a previous study ] It was estimated that a minimum sample size of 19 subjects (sides) per group for a total of 38 sides would be essential for an effect size of 0.97 with an alpha error of 0.05 and a power beta of 0.90 to achieve 95% confidence of a true difference between the groups. Sample size was increased by 25% to 25 subjects per group for a total of 50 sides to compensate for drop-outs. Patient selection and preparation: All root canal treatments were performed by a single endodontic consultant. All subjects were selected from walk in patients presented to the endodontic clinic of the British university in Egypt. Cases that were diagnosed and did not meet the inclusion criteria were referred to the intern clinic for dental care. Cases that met the inclusion criteria where selected for this study. All patients were verbally informed about the procedure's benefits and that the results of the treatment will be used to this study and the risks of the procedure was explicitly explained to them. After the verbal consent patients were handed a written form consent to sign upon. Procedure: Radiographs were taken by a Paralleled long cone periapical radiography. To ensure a visible root canal ≤30° of canal curvature and a periapical index (PAI score) of 3-5 in addition of initial confirmation of root canal types. All patients were anesthetized, rubber dam applied, and access cavities were performed. After root canal exploration and scouting, root canal systems were reconfirmed to be the types selected for this study. Initial binding file was selected for all root canals to ensure it met the inclusion size of mesial roots #20 and distal #30. After patency and glide path were performed by K-files up to size #20, engine driven canal enlargement was applied using E3 Azure files to final finishing size according to the grouping. Group A: (left side of the patient) were prepared 2 sizes larger than the IBF, to size 35#/.04 mesial canals and 40#/.04 distal canals. Group B: (right side of the patient) were prepared 3 sizes larger than the IBF, to size 40#/.04 mesial canals and 45#/.04 distal canals. All data of post-operative pain were recorded by a second blinded clinician through a visual analog scale (VAS). Post-operative monitoring periods will be recorded in 12 hours, 24 hours, 3 days and 1 week. Data was sent to the statistician with group names only to fulfill the triple blinding criteria and results will be interpreted


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date April 15, 2023
Est. primary completion date March 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 50 Years
Eligibility Inclusion Criteria: - Age: 20-50 - Gender: Males and Females, random selection. - Systemic status: healthy patients (Category: American Society of Anaesthesiologists class 1) - Bilateral exposed mandibular first or second permanent molars - Molars should have separate mesial and distal roots - Mesial roots confirmed to be type three root canal system - Distal root confirmed to be type one root canal system - Normal periapical radiograph and no bone changes - Symptomatic irreversible pulpitis - I.B.F. in mesial roots not more than #20, and distal root not more than #30 Exclusion Criteria: - Type two root canal system in mesial roots - Type two or three root canal systems in distal roots - Signs of apical involvement in the radiograph - Any systemic conditions altering the treatment or requiring medications or precautions

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Pain assessment
Pain was assesd postoperatively in both groups at time intervals

Locations

Country Name City State
Egypt British university Cairo El Shrouk

Sponsors (1)

Lead Sponsor Collaborator
British University In Egypt

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain assessment at 12 hours post-operative pain will be recorded by a second blinded clinician using a visual analog scale where patient grades his level of pain from minimum to maximum Post-operative monitoring periods wiere recorded 12 hours
Primary Pain assessment at 24 hours Comparative post-operative pain will be recorded by a second blinded clinician using a visual analog scale where patient grades his level of pain from minimum to maximum Post-operative monitoring periods wiere recorded 24 hours
Primary Pain assessment at 3 days post-operative pain will be recorded by a second blinded clinician using a visual analog scale where patient grades his level of pain from minimum to maximum Post-operative monitoring periods wiere recorded 3days
Primary Pain assessment at 1 week post-operative pain will be recorded by a second blinded clinician using a visual analog scale where patient grades his level of pain from minimum to maximum Post-operative monitoring periods wiere recorded 1 week
See also
  Status Clinical Trial Phase
Completed NCT00361582 - A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery Phase 3
Completed NCT02749461 - Validation of the Bernese Pain Scale for Neonates N/A
Recruiting NCT05405257 - Oxytocin for Hypermobile Ehlers-Danlos Syndrome Phase 1/Phase 2
Completed NCT06236035 - Intraoperative Analgesia Based on ANI
Recruiting NCT04228705 - Establishment and Validation of Early-warning Model of Perioperative Pain for the Elders
Completed NCT03613012 - Pain Index Extracted From EEG in Monitoring Chronic Pain
Completed NCT00364247 - A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety. Phase 3